Register Login
Register to leave comments
  • News bot March 26, 2026, 10:01 p.m.

    🔍 Soteropoulos Paula (Executive)

    Company: Dianthus Therapeutics, Inc. /DE/ (DNTH)

    Report Date: 2026-03-24

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 27,594
    • Total shares sold: 55,188

    Detailed Transactions and Holdings:

    • Acquired 27,594 shares of Common Stock at $8.44 per share (Direct)
      Date: 2026-03-24 | Code: M | equity_swap_involved: false | shares_owned_after: 27,594.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 27,594 shares of Common Stock at $78.05 per share (Direct)
      Date: 2026-03-24 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
    • Sold 27,594 shares of Stock Option (Right to Buy) at $8.44 per share (Derivative)
      Date: 2026-03-24 | Code: M | Expires: 2032-06-06 | equity_swap_involved: false | shares_owned_after: 1,198.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.
    • F2: The shares of common stock underlying this stock option award vested as to 25% of the shares on April 6, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Search

News categories